Nickel catalysts based on phenyl ether-pyrazol ligands: Synthesis, XPS study, and use in ethylene oligomerization

Authors:   Ana H.D.P.S. Ulbrich, Roberta R. Campedelli, Jorge L. Sônego Milani, João H.Z. dos Santos, Osvaldo de L. Casagrande Jr.

Abstract:
A series of nickel(II) complexes bearing phenyl ether-pyrazol ligands [NiCl2L](Ni1: L = 3,5-dimethyl-1-(3- phenoxypropyl)-1H-pyrazole; Ni2: L = 1-(3-phenoxypropyl)-3-phenyl-1H-pyrazole; Ni3: L = 3,5-di-tertbutyl-1-(3-phenoxypropyl)-1H-pyrazole; Ni4: L = 1-(3-phenoxypropyl)-1H-pyrazole) were synthesized and fully characterized by elemental analysis, high-resolution mass spectrometry (HRMS) and X-ray photoelectron spectroscopy (XPS).X-ray photoelectron data illustrates thatthe probability of(co)existing dimeric species increases in the following order: Ni4 < Ni1 < Ni2 < Ni3. All nickel precatalysts, activated with methylaluminoxane (MAO), exhibited moderate to high activities for ethylene oligomerization [TOF = 18.4–45.7 × 103 mol(ethylene)(mol(Ni))−1 h−1)] with good selectivities for 1-butene produced (62.6–80.7%). The ligand environment regarding the substituents on the pyrazolyl unit as well as the reaction parameters influence the catalytic performance and selectivity toward production of 1-butene. When activated with ethylaluminum sesquichloride (Et3Al2Cl3, EASC), Ni1 displayed low catalytic activity (TOF = 9300 (mol C2H4)·(mol Ni⁻¹ h⁻¹); however, the 1-butene selectivity was increased, attaining 92.5%. The use of triphenylphosphine (PPh3) as auxiliary ligand afforded highly active catalyst system [TOF = 118.3 × 10³ mol(ethylene)(mol(Ni))⁻¹ h⁻¹)] with poor selectivity for production of 1-butene (13.7%).

Keywords:
Nickel(II) complexes
Phenyl ether-pyrazol ligands
Ethylene oligomerization
1-butene
XPS studies

Published in: Applied catalysis A: General  (Volume 453, Pages 1-402, 26 February 2013)

Publisher: Elsevier

ISSN Information: 0926-860X

Nickel catalysts based on phenyl ether-pyrazol ligands: Synthesis, XPS study, and use in ethylene oligomerization

Bình luận của bạn

*

*

*

*

 Captcha

Gửi bình luận nhập lại